Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension (CO in PAH)
This study has been withdrawn prior to enrollment.
(Lack of funding and subject acuity)
University of Illinois at Chicago
First Posted: February 1, 2012
Last Update Posted: June 9, 2017
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Roberto Machado, M.D., University of Illinois at Chicago
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||December 2018|
|Estimated Primary Completion Date:||December 2018 (Final data collection date for primary outcome measure)|